SUBSCRIBE
SUBSCRIBE

Spero Therapeutics

NEWS
Genetown
SEC Filings Reveal GlaxoSmithKline’s 13% Stake in This Massachusetts Biotech
A filing with the SEC indicates that Glaxo now has a 13 percent stake in Spero Therapeutics.
November 17, 2017
 · 
3 min read
 · 
Mark Terry
Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub
Genetown
Backed by Google, Cambridge’s Spero Nabs $51.7 Million Series C
March 8, 2017
 · 
2 min read
Business
Top 20 Life Science Startups to Watch in the U.S.
BioSpace is pleased to present its NextGen Bio “Class of 2016.” This list contains 20 life science companies that launched no earlier than 2013 and are headquartered in the United States.
January 26, 2016
 · 
15 min read
 · 
Mark Terry
What You Need to Know About Spero
Business
What You Need to Know About Spero
December 2, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Merck & Co., New England Patriots Owner Wager $30 Million on Cambridge Startup, Spero
June 8, 2015
 · 
4 min read
Load More
AWARDS
  • NextGen Class of 2016
JOBS
IN THE PRESS
Genetown
Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference
May 16, 2024
 · 
2 min read
Business
Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update
May 15, 2024
 · 
10 min read
Business
Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024
May 8, 2024
 · 
1 min read
Genetown
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 01, 2024
May 1, 2024
 · 
2 min read
Business
Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update
March 13, 2024
 · 
13 min read
Business
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
March 6, 2024
 · 
1 min read
Drug Development
Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections
February 28, 2024
 · 
7 min read
Genetown
Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference
February 26, 2024
 · 
4 min read
Genetown
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 31, 2024
January 31, 2024
 · 
2 min read
Genetown
Spero Therapeutics Provides Corporate Update and 2024 Outlook
January 5, 2024
 · 
7 min read
Load More